Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 145

1.

Ovarian cancer and hormone replacement therapy in the Million Women Study.

Beral V; Million Women Study Collaborators., Bull D, Green J, Reeves G.

Lancet. 2007 May 19;369(9574):1703-10.

PMID:
17512855
2.

Breast cancer and hormone-replacement therapy in the Million Women Study.

Beral V; Million Women Study Collaborators..

Lancet. 2003 Aug 9;362(9382):419-27. Erratum in: Lancet. 2003 Oct 4;362(9390):1160.

PMID:
12927427
4.

Hormone therapy and ovarian cancer.

Mørch LS, Løkkegaard E, Andreasen AH, Krüger-Kjaer S, Lidegaard O.

JAMA. 2009 Jul 15;302(3):298-305. doi: 10.1001/jama.2009.1052.

PMID:
19602689
5.

Endometrial cancer and hormone-replacement therapy in the Million Women Study.

Beral V, Bull D, Reeves G; Million Women Study Collaborators..

Lancet. 2005 Apr 30-May 6;365(9470):1543-51.

PMID:
15866308
6.

Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies.

Collaborative Group On Epidemiological Studies Of Ovarian Cancer., Beral V, Gaitskell K, Hermon C, Moser K, Reeves G, Peto R.

Lancet. 2015 May 9;385(9980):1835-42. doi: 10.1016/S0140-6736(14)61687-1. Epub 2015 Feb 13.

7.

Hormonal therapy for menopause and ovarian cancer in a collaborative re-analysis of European studies.

Negri E, Tzonou A, Beral V, Lagiou P, Trichopoulos D, Parazzini F, Franceschi S, Booth M, La Vecchia C.

Int J Cancer. 1999 Mar 15;80(6):848-51.

8.

Hormone replacement therapy and incidence of central nervous system tumours in the Million Women Study.

Benson VS, Pirie K, Green J, Bull D, Casabonne D, Reeves GK, Beral V; Million Women Study Collaborators..

Int J Cancer. 2010 Oct 1;127(7):1692-8. doi: 10.1002/ijc.25184.

9.

Hormone replacement therapy and incidence of hormone-dependent cancers in the Norwegian Women and Cancer study.

Bakken K, Alsaker E, Eggen AE, Lund E.

Int J Cancer. 2004 Oct 20;112(1):130-4.

10.

A prospective study of postmenopausal hormone use and ovarian cancer risk.

Danforth KN, Tworoger SS, Hecht JL, Rosner BA, Colditz GA, Hankinson SE.

Br J Cancer. 2007 Jan 15;96(1):151-6. Epub 2006 Dec 19.

11.

Hormone replacement therapy and breast cancer in former users of oral contraceptives--The Norwegian Women and Cancer study.

Lund E, Bakken K, Dumeaux V, Andersen V, Kumle M.

Int J Cancer. 2007 Aug 1;121(3):645-8.

12.

Increased incidence of small and well-differentiated breast tumours in post-menopausal women following hormone-replacement therapy.

Manjer J, Malina J, Berglund G, Bondeson L, Garne JP, Janzon L.

Int J Cancer. 2001 Jun 15;92(6):919-22.

13.

Hormonal therapy for menopause and breast-cancer risk by histological type: a cohort study and meta-analysis.

Reeves GK, Beral V, Green J, Gathani T, Bull D; Million Women Study Collaborators..

Lancet Oncol. 2006 Nov;7(11):910-8.

PMID:
17081916
14.

Postmenopausal hormone use and incident ovarian cancer: Associations differ by regimen.

Hildebrand JS, Gapstur SM, Feigelson HS, Teras LR, Thun MJ, Patel AV.

Int J Cancer. 2010 Dec 15;127(12):2928-35. doi: 10.1002/ijc.25515.

15.

Estrogen replacement therapy and ovarian cancer mortality in a large prospective study of US women.

Rodriguez C, Patel AV, Calle EE, Jacob EJ, Thun MJ.

JAMA. 2001 Mar 21;285(11):1460-5.

PMID:
11255422
16.

Evidence from randomised trials on the long-term effects of hormone replacement therapy.

Beral V, Banks E, Reeves G.

Lancet. 2002 Sep 21;360(9337):942-4. Review.

PMID:
12354487
19.

Menopausal hormone therapy and ovarian cancer risk in the National Institutes of Health-AARP Diet and Health Study Cohort.

Lacey JV Jr, Brinton LA, Leitzmann MF, Mouw T, Hollenbeck A, Schatzkin A, Hartge P.

J Natl Cancer Inst. 2006 Oct 4;98(19):1397-405.

PMID:
17018786
20.

Hormone replacement therapy and cancer.

[No authors listed]

Gynecol Endocrinol. 2001 Dec;15(6):453-65. Review.

PMID:
11826770

Supplemental Content

Support Center